Met Life Investment Management, LLC Ligand Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 9,940 shares of LGND stock, worth $1.18 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,940
Previous 9,940 -0.0%
Holding current value
$1.18 Million
Previous $837,000 18.88%
% of portfolio
0.01%
Previous 0.01%

Shares

61 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $78,329 - $100,481
1,143 Added 12.99%
9,940 $837,000
Q1 2024

May 14, 2024
BUY
$68.64 - $89.2 $603,826 - $784,692
8,797 New
8,797 $643,000
Q3 2023

May 09, 2024
BUY
$58.86 - $72.67 $41,143 - $50,796
699 Added 8.63%
8,797 $527,000
Q2 2023

Apr 29, 2024
BUY
$69.53 - $79.33 $611,655 - $697,866
8,797 New
8,797 $634,000
Q2 2023

Aug 10, 2023
BUY
$69.53 - $79.33 $48,601 - $55,451
699 Added 8.63%
8,797 $634,000
Q1 2023

May 09, 2024
BUY
$65.67 - $77.08 $531,795 - $624,193
8,098 New
8,098 $596 Million
Q1 2023

May 15, 2023
SELL
$65.67 - $77.08 $34,082 - $40,004
-519 Reduced 6.02%
8,098 $595,000
Q4 2022

Jun 14, 2023
BUY
$61.72 - $96.74 $32,032 - $50,208
519 Added 6.41%
8,617 $575,000
Q3 2022

Jun 14, 2023
BUY
$0.01 - $107.56 $5 - $55,823
519 Added 6.41%
8,617 $742,000
Q2 2022

Jun 20, 2023
BUY
$74.52 - $117.06 $38,675 - $60,754
519 Added 6.41%
8,617 $768,000
Q1 2022

May 10, 2024
BUY
$94.99 - $151.56 $818,528 - $1.31 Million
8,617 New
8,617 $969,000
Q1 2022

Jun 20, 2023
BUY
$94.99 - $151.56 $49,299 - $78,659
519 Added 6.41%
8,617 $969,000
Q1 2022

Mar 22, 2023
BUY
$94.99 - $151.56 $290,004 - $462,712
3,053 Added 54.87%
8,617 $969,000
Q1 2022

May 12, 2022
BUY
$94.99 - $151.56 $290,004 - $462,712
3,053 Added 54.87%
8,617 $969,000
Q4 2021

Jun 21, 2023
SELL
$127.69 - $165.85 $323,566 - $420,263
-2,534 Reduced 31.29%
5,564 $859,000
Q3 2021

May 17, 2024
SELL
$102.33 - $144.73 $851,487 - $1.2 Million
-8,321 Reduced 59.93%
5,564 $775,000
Q3 2021

Jun 21, 2023
SELL
$102.33 - $144.73 $259,304 - $366,745
-2,534 Reduced 31.29%
5,564 $775,000
Q3 2021

Mar 22, 2023
SELL
$102.33 - $144.73 $851,487 - $1.2 Million
-8,321 Reduced 59.93%
5,564 $775,000
Q3 2021

Nov 15, 2021
SELL
$102.33 - $144.73 $851,487 - $1.2 Million
-8,321 Reduced 59.93%
5,564 $775,000
Q2 2021

May 17, 2024
SELL
$113.03 - $155.64 $29,387 - $40,466
-260 Reduced 1.84%
13,885 $1.82 Million
Q2 2021

Jun 21, 2023
BUY
$113.03 - $155.64 $654,104 - $900,688
5,787 Added 71.46%
13,885 $1.82 Million
Q2 2021

Mar 22, 2023
SELL
$113.03 - $155.64 $29,387 - $40,466
-260 Reduced 1.84%
13,885 $1.82 Million
Q2 2021

Aug 16, 2021
SELL
$113.03 - $155.64 $29,387 - $40,466
-260 Reduced 1.84%
13,885 $1.82 Million
Q1 2021

May 17, 2024
BUY
$99.52 - $215.83 $532,232 - $1.15 Million
5,348 Added 60.79%
14,145 $2.16 Million
Q1 2021

Jun 26, 2023
BUY
$99.52 - $215.83 $601,797 - $1.31 Million
6,047 Added 74.67%
14,145 $2.16 Billion
Q1 2021

Mar 22, 2023
SELL
$99.52 - $215.83 $109,770 - $238,060
-1,103 Reduced 7.23%
14,145 $2.16 Million
Q1 2021

May 14, 2021
SELL
$99.52 - $215.83 $109,770 - $238,060
-1,103 Reduced 7.23%
14,145 $2.16 Million
Q4 2020

May 24, 2024
SELL
$80.55 - $106.05 $32,622 - $42,950
-405 Reduced 2.59%
15,248 $1.52 Million
Q4 2020

Jun 22, 2023
BUY
$80.55 - $106.05 $575,932 - $758,257
7,150 Added 88.29%
15,248 $1.52 Million
Q4 2020

Mar 22, 2023
SELL
$80.55 - $106.05 $32,622 - $42,950
-405 Reduced 2.59%
15,248 $1.52 Million
Q4 2020

Feb 16, 2021
SELL
$80.55 - $106.05 $32,622 - $42,950
-405 Reduced 2.59%
15,248 $1.52 Million
Q3 2020

May 24, 2024
SELL
$89.56 - $126.72 $29,196 - $41,310
-326 Reduced 2.04%
15,653 $1.49 Billion
Q3 2020

Jun 26, 2023
BUY
$89.56 - $126.72 $676,625 - $957,369
7,555 Added 93.29%
15,653 $1.49 Million
Q3 2020

Mar 22, 2023
SELL
$89.56 - $126.72 $29,196 - $41,310
-326 Reduced 2.04%
15,653 $1.49 Million
Q3 2020

Nov 13, 2020
SELL
$89.56 - $126.72 $29,196 - $41,310
-326 Reduced 2.04%
15,653 $1.49 Million
Q2 2020

May 24, 2024
BUY
$68.28 - $123.65 $490,386 - $888,054
7,182 Added 81.64%
15,979 $1.79 Billion
Q2 2020

Jun 26, 2023
BUY
$68.28 - $123.65 $538,114 - $974,485
7,881 Added 97.32%
15,979 $1.79 Million
Q2 2020

Mar 22, 2023
SELL
$68.28 - $123.65 $65,753 - $119,074
-963 Reduced 5.68%
15,979 $1.79 Million
Q2 2020

Aug 14, 2020
SELL
$68.28 - $123.65 $65,753 - $119,074
-963 Reduced 5.68%
15,979 $1.79 Million
Q1 2020

Jul 12, 2023
BUY
$63.37 - $107.88 $560,444 - $954,090
8,844 Added 109.21%
16,942 $1.23 Million
Q1 2020

Mar 22, 2023
SELL
$63.37 - $107.88 $38,465 - $65,483
-607 Reduced 3.46%
16,942 $1.23 Million
Q1 2020

May 15, 2020
SELL
$63.37 - $107.88 $38,465 - $65,483
-607 Reduced 3.46%
16,942 $1.23 Million
Q4 2019

Jul 12, 2023
BUY
$96.94 - $113.59 $916,179 - $1.07 Million
9,451 Added 116.71%
17,549 $1.83 Million
Q4 2019

Mar 22, 2023
SELL
$96.94 - $113.59 $194,558 - $227,975
-2,007 Reduced 10.26%
17,549 $1.83 Million
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $194,558 - $227,975
-2,007 Reduced 10.26%
17,549 $1.83 Million
Q3 2019

Jul 12, 2023
BUY
$86.25 - $120.16 $988,252 - $1.38 Million
11,458 Added 141.49%
19,556 $1.95 Million
Q3 2019

Mar 22, 2023
SELL
$86.25 - $120.16 $119,542 - $166,541
-1,386 Reduced 6.62%
19,556 $1.95 Million
Q3 2019

Nov 14, 2019
SELL
$86.25 - $120.16 $119,542 - $166,541
-1,386 Reduced 6.62%
19,556 $1.95 Million
Q2 2019

Jul 12, 2023
BUY
$107.38 - $129.34 $1.38 Million - $1.66 Million
12,844 Added 158.61%
20,942 $2.39 Million
Q2 2019

Mar 22, 2023
SELL
$107.38 - $129.34 $88,481 - $106,576
-824 Reduced 3.79%
20,942 $2.39 Million
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $88,481 - $106,576
-824 Reduced 3.79%
20,942 $2.39 Million
Q1 2019

Jul 13, 2023
BUY
$105.93 - $142.47 $1.45 Million - $1.95 Million
13,668 Added 168.78%
21,766 $2.74 Million
Q1 2019

Mar 22, 2023
SELL
$105.93 - $142.47 $52,541 - $70,665
-496 Reduced 2.23%
21,766 $2.74 Million
Q1 2019

May 15, 2019
SELL
$105.93 - $142.47 $52,541 - $70,665
-496 Reduced 2.23%
21,766 $2.74 Million
Q4 2018

Jul 13, 2023
BUY
$128.36 - $272.13 $1.82 Million - $3.85 Million
14,164 Added 174.91%
22,262 $3.02 Million
Q4 2018

Mar 22, 2023
BUY
$128.36 - $272.13 $982,980 - $2.08 Million
7,658 Added 52.44%
22,262 $3.02 Million
Q4 2018

Feb 14, 2019
BUY
$128.36 - $272.13 $982,980 - $2.08 Million
7,658 Added 52.44%
22,262 $3.02 Million
Q3 2018

Jul 13, 2023
BUY
$211.18 - $274.49 $260,384 - $338,446
1,233 Added 15.23%
9,331 $2.56 Million
Q3 2018

Mar 22, 2023
BUY
$211.18 - $274.49 $1.26 Million - $1.64 Million
5,987 Added 69.48%
14,604 $4.01 Million
Q3 2018

Nov 14, 2018
BUY
$211.18 - $274.49 $1.11 Million - $1.45 Million
5,273 Added 56.51%
14,604 $4.01 Million
Q4 2017

Feb 15, 2018
BUY
$128.36 - $147.04 $1.2 Million - $1.37 Million
9,331
9,331 $1.28 Million

Others Institutions Holding LGND

# of Institutions
257
Shares Held
18.2M
Call Options Held
26.8K
Put Options Held
9.3K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.01B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email